{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:30:04Z","timestamp":1767911404046,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.vaccine.2008.02.009","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T12:25:50Z","timestamp":1203596750000},"page":"2020-2033","source":"Crossref","is-referenced-by-count":40,"title":["The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus"],"prefix":"10.1016","volume":"26","author":[{"given":"Bimmi","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Jue","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Noll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2008.02.009_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1586\/14787210.3.6.931","article-title":"Development of effective therapies against West Nile virus infection","volume":"3","author":"Diamond","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.vaccine.2008.02.009_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2001.tb02694.x","article-title":"The West Nile virus encephalitis outbreak in the United States (1999\u20132000): from Flushing, New York, to beyond its borders","volume":"951","author":"Asnis","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2008.02.009_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3201\/eid0505.990506","article-title":"West Nile fever\u2014a reemerging mosquito-borne viral disease in Europe","volume":"5","author":"Hubalek","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2008.02.009_bib4","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1128\/JVI.01122-06","article-title":"Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion","volume":"80","author":"Samuel","year":"2006","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.009_bib5","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.02.009_bib6","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.02.009_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.vaccine.2008.02.009_bib8","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.009_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2008.02.009_bib10","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2008.02.009_bib11","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","article-title":"Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus","volume":"79","author":"Gould","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.009_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/14760584.3.2.199","article-title":"Recent advancement in flavivirus vaccine development","volume":"3","author":"Chang","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2008.02.009_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1749-6632.2001.tb02701.x","article-title":"Use of live and inactivated vaccines in the control of West Nile fever in domestic geese","volume":"951","author":"Malkinson","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"41","key":"10.1016\/j.vaccine.2008.02.009_bib14","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.vaccine.2005.03.052","article-title":"An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application","volume":"23","author":"Samina","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.009_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1086\/431153","article-title":"Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections","volume":"192","author":"Tesh","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.009_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1051\/vetres:2006045","article-title":"Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California","volume":"38","author":"Gardner","year":"2007","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2008.02.009_bib17","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2008.02.009_bib18","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.02.009_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2460\/javma.2004.225.1084","article-title":"Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002)","volume":"225","author":"Schuler","year":"2004","journal-title":"J Am Vet Med Assoc"},{"issue":"11","key":"10.1016\/j.vaccine.2008.02.009_bib20","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2460\/ajvr.2004.65.1459","article-title":"Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses","volume":"65","author":"Siger","year":"2004","journal-title":"Am J Vet Res"},{"issue":"7","key":"10.1016\/j.vaccine.2008.02.009_bib21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/323395","article-title":"Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999)","volume":"184","author":"Yang","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.02.009_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.2001.tb02703.x","article-title":"Flavivirus DNA vaccines: current status and potential","volume":"951","author":"Chang","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2008.02.009_bib23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid0909.030025","article-title":"DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus)","volume":"9","author":"Turell","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2008.02.009_bib24","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.02.009_bib25","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.009_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.009_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/vim.2000.13.401","article-title":"A live attenuated West Nile virus strain as a potential veterinary vaccine","volume":"13","author":"Lustig","year":"2000","journal-title":"Viral Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.009_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2004.09.014","article-title":"An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development","volume":"330","author":"Yamshchikov","year":"2004","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.vaccine.2008.02.009_bib29","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1073\/pnas.1834270100","article-title":"DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus","volume":"100","author":"Hall","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.vaccine.2008.02.009_bib30","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.02.009_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.virol.2006.02.013","article-title":"Biological properties of chimeric West Nile viruses","volume":"349","author":"Borisevich","year":"2006","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.vaccine.2008.02.009_bib32","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2008.02.009_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3201\/eid0704.010408","article-title":"Partial genetic characterization of West Nile virus strains, New York State, 2000","volume":"7","author":"Ebel","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2008.02.009_bib34","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1128\/JVI.00274-06","article-title":"Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection","volume":"80","author":"Shrestha","year":"2006","journal-title":"J Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2008.02.009_bib35","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1128\/JVI.78.13.6836-6845.2004","article-title":"Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency","volume":"78","author":"McClellan","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.009_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/JVI.80.1.119-129.2006","article-title":"CD8+ T cells require perforin to clear West Nile virus from infected neurons","volume":"80","author":"Shrestha","year":"2006","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.02.009_bib37","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system","volume":"80","author":"Sitati","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.02.009_bib38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/eji.200737192","article-title":"Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis","volume":"37","author":"Purtha","year":"2007","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.02.009_bib39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eji.200737196","article-title":"Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection","volume":"37","author":"Brien","year":"2007","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.02.009_bib40","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20031223","article-title":"A critical role for induced IgM in the protection against West Nile virus infection","volume":"198","author":"Diamond","year":"2003","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.009_bib41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0042-6822(92)90317-I","article-title":"Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis","volume":"187","author":"Pincus","year":"1992","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2008.02.009_bib42","doi-asserted-by":"crossref","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","article-title":"Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival","volume":"79","author":"Samuel","year":"2005","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2008.02.009_bib43","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2008.02.009_bib44","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.02.009_bib45","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J Clin Invest"},{"issue":"6722","key":"10.1016\/j.vaccine.2008.02.009_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/18038","article-title":"Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen","volume":"398","author":"Sigal","year":"1999","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2008.02.009_bib47","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/JVI.74.9.4244-4252.2000","article-title":"A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice","volume":"74","author":"Chang","year":"2000","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2008.02.009_bib48","doi-asserted-by":"crossref","first-page":"11457","DOI":"10.1128\/JVI.75.23.11457-11463.2001","article-title":"Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses","volume":"75","author":"Pan","year":"2001","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.02.009_bib49","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.00284-06","article-title":"Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques","volume":"80","author":"Simmons","year":"2006","journal-title":"J Virol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.02.009_bib50","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF01718332","article-title":"Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus","volume":"141","author":"Phillpotts","year":"1996","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.009_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.1998.9357","article-title":"DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus","volume":"250","author":"Colombage","year":"1998","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2008.02.009_bib52","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/JVI.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.02.009_bib53","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/infdis\/174.6.1176","article-title":"Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys","volume":"174","author":"Putnak","year":"1996","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.02.009_bib54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2006.06.033","article-title":"Baboon model for West Nile virus infection and vaccine evaluation","volume":"355","author":"Wolf","year":"2006","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2008.02.009_bib55","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/508293","article-title":"Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters","volume":"194","author":"Morrey","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.02.009_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb02680.x","article-title":"Prospects for development of a vaccine against the West Nile virus","volume":"951","author":"Monath","year":"2001","journal-title":"Ann N Y Acad Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08001370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08001370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T04:31:50Z","timestamp":1588393910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08001370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":56,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0264410X08001370"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.02.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}